A detailed history of Chicago Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Chicago Capital, LLC holds 6,778 shares of NVO stock, worth $964,983. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,778
Previous 4,570 48.32%
Holding current value
$964,983
Previous $472,000 84.32%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $225,458 - $300,111
2,208 Added 48.32%
6,778 $870,000
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $401,154 - $481,906
4,570 New
4,570 $472,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.